Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
compounding
Marketing
Semaglutide compounder drops claims after Novo Nordisk challenge
A Novo Nordisk challenge has driven Regen Doctors to voluntarily drop compounded semaglutide claims, adding to the Danish drugmaker’s string of wins.
Nick Paul Taylor
Nov 21, 2025 9:20am
Novo plots board shake-up after stalemate in leadership talks
Oct 21, 2025 11:36am
Novo Nordisk unveils $499 cash-pay Ozempic offering
Aug 18, 2025 11:01am
Novo's new CEO takes over at difficult time for drugmaker
Aug 6, 2025 11:43am
Experts hold line against mass compounding of GLP-1 obesity meds
Jun 27, 2025 10:36am
Novo inks Wegovy deals with telehealth companies
Apr 29, 2025 11:05am
